Table V.
General Health Outcomes in Transgender Research (n=68 Data Points).
| General Health Indicator (40 total unique general health indicators) | # Data Points |
|---|---|
| Diabetes | 8 |
| Hormone Use (4 on previous 30 days, 3 on non-prescribed, 1 on injected hormones) | 8 |
| Obesity | 5 |
| Metabolic syndrome (ATP-III) | 3 |
| Asthma | 2 |
| Cancer | 2 |
| Dyslipidemia | 2 |
| Familial hypercolesterolemia | 2 |
| General medical condition co-morbidity | 2 |
| Hypertension | 2 |
| Mortality External causes | 2 |
| Venous thrombosis and/or pulmonary embolism | 2 |
| All cause mortality | 1 |
| Arthritis | 1 |
| Blood pressure | 1 |
| Cardiovascular mortality | 1 |
| Chronic pain | 1 |
| Cryptorchidism | 1 |
| Digestive problems | 1 |
| Disability | 1 |
| Hearing | 1 |
| High cholesterol | 1 |
| Hyperandrogenism | 1 |
| Hypercolesterolemia | 1 |
| Hyperprolactinemia | 1 |
| Idiopathic hyperadrogenemia | 1 |
| Kidney problems | 1 |
| Lung problems | 1 |
| Metabolic syndrome (IDF) | 1 |
| Mortality Ischemic heart disease | 1 |
| Mortality Malignant neoplasm: Digestive tract | 1 |
| Mortality Malignant neoplasm: Hematological | 1 |
| Mortality Malignant neoplasm: Lung | 1 |
| Mortality Unknown cause | 1 |
| Myocardial infarction | 1 |
| Nonclassic adrenal hyperplasia | 1 |
| Primary hypogonadism | 1 |
| Secondary hypogonadism | 1 |
| Transient ischemic attack; cerebrovascular disease | 1 |
| Vision problems | 1 |